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TRPCDischarge of the intracellular Ca2+ stores activates Ca2+ entry through store-operated channels (SOCs). Since
the recent identiﬁcation of STIM1 and STIM2, as well as the Orai1 homologs, Orai2 and Orai3, the protein
complexes involved in Ca2+ signaling needs re-evaluation in native cells. Using real time PCR combined
with Western blotting we have found the expression of the three Orai isoforms, STIM1, STIM2 and different
TRPCs in human platelets. Depletion of the intracellular Ca2+ stores with thapsigargin, independently of
changes in cytosolic Ca2+ concentration, enhanced the formation of a signaling complex involving STIM1,
STIM2, Orai1, Orai2 and TRPC1. Furthermore, platelet treatment with the dyacylglicerol analog 1-oleoyl-2-
acetyl-sn-glycerol (OAG) resulted in speciﬁc association of Orai3 with TRPC3. Treatment of platelets with
arachidonic acid enhanced the association between Orai1 and Orai3 in human platelets and overexpression
of Orai1 and Orai3 in HEK293 cells increased arachidonic acid-induced Ca2+ entry. These results indicate
that Ca2+ store depletion results in the formation of exclusive signaling complexes involving STIM proteins,
as well as Orai1, Orai2 and TRPC1, but not Orai3, which seems to be involved in non-capacitative Ca2+ inﬂux
in human platelets.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Receptor-operated Ca2+ entry is a ubiquitous and important mecha-
nism for Ca2+ inﬂux in excitable and non-excitable cells. This mecha-
nism comprises Ca2+ entry pathways activated by receptor occupation,
from the non-capacitative Ca2+ currents via receptor-channels them-
selves or through channels operated by second messengers to the
capacitative Ca2+ entry pathway activated by discharge of the intracellu-
lar Ca2+ pools via store-operated Ca2+ channels (SOCs) [1]. Capacitative
or store-operated Ca2+ entry (SOCE) is a complexmechanism controlled
by the ﬁlling state of the intracellular Ca2+ stores. In 2005, the protein
STIM1 was identiﬁed as the endoplasmic reticulum (ER) Ca2+ sensor
that communicates the information of the ﬁlling state of the ER to SOCs
located in the plasma membrane [2]. Concerning SOCs, the canonical
human homologs of Drosophila transient receptor potential channels
(TRPC), particularly TRPC1, have been presented as candidates to medi-
ate non Ca2+-selective capacitative currents (ISOC) [3]. In 2006, Orai1was
presented as the pore unit of the channel that mediate ICRAC, the best
characterized and Ca2+-selective capacitative current [4,5], and a num-
ber of studies demonstrated that co-expression of STIM1 and Orai1 is
able to enhance ICRAC [6] or to successfully reconstitute ICRAC-like signals
in HEK-293 cells [7]. Isoforms of these proteins, STIM2, Orai2 and Orai3,
have also been identiﬁed, although their role in intracellular Ca2+ ho-
meostasis is less characterized [8].y, University of Extremadura,
927257110.
l rights reserved.STIM2 is almost ubiquitously expressed in human tissues and has
been found located in the ER membrane and in the membrane of
acidic intracellular Ca2+ stores [9–11], but not in the plasma mem-
brane in contrast to STIM1 [10,12]. Nevertheless, the function of
STIM2 is still unclear. By using STIM2 knockdown expression, it has
been suggested that STIM2 acts as a regulator that stabilizes resting
Ca2+ concentration in the cytosol and the ER [13]. Concerning SOCE,
STIM2 has been shown to be able to interact with Orai proteins and
TRPC1 channels [6,14], thus suggesting a potential role in SOCE. Stud-
ies performed by Gill's group suggested that STIM2 inhibits SOCE
when expressed alone [10], but induces constitutive SOCE when co-
expressed with Orai1 [6]. Further studies have reported different de-
grees of attenuation of SOCE in the absence of STIM2 expression in a
variety of cells [15,16], and STIM2-mediated Ca2+ entry via two
store-dependent and store-independent modes in HEK293 cells [14].
Orai2 andOrai3 are alsowidely expressed in different human tissues
[17,18]. Knockdown gene expression in a variety of cell lines has re-
vealed that Orai2 and Orai3 have a minor role in SOCE than Orai1
[19–21]. The functional properties of Orai3 have been shown to be
slightly different to those of Orai1 and Orai2. The latter show similarly
fast activation kinetics while Orai3 shows slower activation. In addition,
Orai3 is more permeant to monovalent cations than Orai1 and Orai2
[22]. Co-expression of STIM1 and Orai1 or Orai2 channels increased
SOCE in HEK293 cells [7] andmouse [23], indicating that these isoforms
interact and are activated by STIM1. In contrast, no signiﬁcant increases
in SOCE were found in cells co-expressing STIM1 and Orai3 [7].
In the present study we have investigated the expression and in-
teraction of the different isoforms of Orai and STIM proteins and the
Table 1
Primers.
Gene Forward (5′–3′) Reverse (5′–3′) Bp. Anneal T.
(°C)
Ref.
hTRPC1 tgcgtagatgtgcttgggag atgctctcagaattggatcc 377 54.6 [51]
hTRPC3 cgatctggtatgagaacc cagtccatgtaaactggg 216 48
hTRPC6 tcatcatggtgtttgtggc gcaaaacaatgaccattgtaa 237 56.5 [52]
hOrai1 agcaacgtgcacaatctcaa gtcttatggctaaccagtga 344 56.5 [23]
hOrai2 cggccataagggcatggatt ttgtggatgttgctcacggc 333 56.5 [23]
hOrai3 ctcttccttgctgaagttgt cgattcagttcctctagttc 354 56.5 [23]
hSTIM1 cagtgaaacacagcaccttcc aagagcactgtatccagagcc 213 56.5 [53]
hSTIM2 ccagggctttcactgtgatt cctcggcttaaggttgtgaa 147 60 [54]
hβ-actin agcgagcatcccccaaagtt gggcacgaaggctcatcatt 285 48–60 [55]
Fig. 1. Quantiﬁcation of Orai, STIM and TRPC mRNA transcripts in human platelets.
A, Representative picture of semi-quantitative RT-PCR products separated by electrophoresis
in agarose gels. B, qRT-PCR expression analysis of TRPC(1, 3, 6), Orai(1–3) and STIM(1–2)
mRNA transcripts in human platelets. Values were normalized to β-actin expression and
represented as (mean expression relative to Orai1±S.E.M; n=3).
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sponse to store depletion or stimulation with the soluble analog of
the second messenger diacylglycerol, 1-oleoyl-2-acetyl-sn-glycerol
(OAG). Our results suggest that, while Orai1 and Orai2 operate in a
STIM-dependent manner, Orai3 does not interact with STIM isoforms
upon store depletion in these cells.
2. Materials and methods
2.1. Materials
Apyrase (grade VII), aspirin, thapsigargin (TG), bovine serum albu-
min (BSA), phenylmethylsulfonyl ﬂuoride (PMSF), arachidonic acid,
1-oleoyl-2-acetyl-sn-glycerol (OAG) and rabbit anti-Orai1 antibody
were purchased from Sigma (Madrid, Spain). Goat anti-hTRPC6 poly-
clonal antibody, horseradish peroxidase-conjugated goat anti-rabbit
IgG antibody and horseradish peroxidase-conjugated donkey anti-
goat IgG antibody were from Santa Cruz (Santa Cruz, CA, U.S.A). Rabbit
anti-TRPC1 antibodywas from Alomone Labs (Jerusalem, Israel). Rabbit
anti-TRPC3 polyclonal antibody, rabbit anti Orai-2 polyclonal antibody
and rabbit anti Orai-3 polyclonal antibody were from Abcam
(Cambridge, U.K.). Mouse anti STIM1 antibody was from BD Transduc-
tion Laboratories (Frankin Lakes, NJ, U.S.A). Rabbit polyclonal anti-
STIM2 antibody was from Cell Signaling (Boston, MA, U.S.A). Hyperﬁlm
ECL was from Amersham (Buckinghamshire, U.K.). Transpass transfec-
tion reagent was from Izasa (Madrid, Spain). Protein A-agarose was
fromUpstate Biotechnology Inc. (Madrid, Spain). Enhanced chemilumi-
nescence detection reagents and rabbit anti-mouse IgG were from
Pierce (Cheshire, U.K.). All other reagents were of analytical grade.
2.2. Platelet preparation
Platelets were prepared as previously described [24] as approved by
Local Ethical Committees and in accordance with the Declaration of
Helsinki. Brieﬂy, blood was obtained from healthy drug-free volunteers
and mixed with one-sixth volume of acid/citrate dextrose anticoagulant
containing (in mM): 85 sodium citrate, 78 citric acid and 111 D-glucose.
Platelet-rich plasma (PRP) was then prepared by centrifugation for
5 min at 700 ×g and aspirin (100 μM) and apyrase (40 μg/mL) were
added. For dimethyl BAPTA loading, the platelet-rich plasmawas incubat-
ed at 37 °C with 10 μM dimethyl BAPTA acetoxymethyl ester for 20 min.
Cells were then collected by centrifugation at 350 ×g for 20 min and
resuspended in HEPES-buffered saline (HBS), pH 7.45, containing (in
mM): 145 NaCl, 10 HEPES, 10 D-glucose, 5 KCl, 1 MgSO4 and sup-
plemented with 0.1% BSA and 40 μg/mL apyrase.
2.3. Cell culture
Human embryonic kidney 293 (HEK293) cells were obtained from
the American Type Culture Collection (Barcelona, Spain) and cultured
in Dulbecco's modiﬁed Eagle's medium, supplemented with 10% heat-
inactivated fetal bovine serum, in a 37 °C incubator with 5% CO2. At
the time of the experiments cells were suspended in HEPES-buffered
saline (HBS) containing (in mM): 145 NaCl, 10 HEPES, 10 D-glucose, 5
KCl, 1 MgSO4, 1 mM CaCl2, pH 7.45. Orai1 and Orai3 cDNA plasmids
were kindly provided by Dr. Trebak and Dr. Romanin, respectively.
Cells were transiently transfected with plasmids using the transpass
transfection reagent, and used 1–3 d after transfection as previously
described [25].
2.4. Real time-PCR
RNA was extracted from isolated human platelets using TRIzol®
reagent (Invitrogen, Carlsbad, CA) according tomanufacturer's speciﬁca-
tions, and 2.5 μg of total RNA was subsequently reverse-transcribed to
single-strand cDNA using SuperScript® VILO™ cDNA Synthesis Kit(Invitrogen, Carlsbad, CA). Single-strand cDNA products were directly
used for PCR ampliﬁcation performedwith an EppendorffMastercycler®
thermal cycler (Eppendorf AG, Hamburg-Eppendorf, Germany). PCR
reagents such as Taq polymerase and buffers were purchased from
TAKARA (Takara Bio Inc., Otsu, Shiga, Japan). PCR products were obtained
using the following cycling conditions: 96 °C for 2 min, followed by 35 cy-
cles of 96 °C for 15 s, 48–56 °C for 25 s, 72 °C for 30 s, and ﬁnished with
72 °C for 10 min. Primers listed in Table 1 were used to amplify cDNA
transcripts of human TRPC1, TRPC3, TRPC6, Orai1, Orai2, Orai3, STIM1 and
STIM2 genes. PCR products were separated by electrophoresis in 1.5%
agarose gels (Roth, Germany) and the resulting bands were documented
and subsequently isolated from gels using UltraClean® PCR Clean-Up Kit
(MO BIO Laboratories Inc., Carlsbad, CA). Ampliﬁcation of the desired
genes was conﬁrmed by sequenciation of PCR products (STAB-SAIUex,
University of Extremadura, Spain).
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Total RNA isolation and single-strand cDNA synthesis was per-
formed in puriﬁed platelets as described above. SYBR green qRT-PCR
was performed using SYBR® Premix Ex Taq™ (Takara Bio Inc., Otsu,
Shiga, Japan) in an Applied Biosystems STEPONE Real-Time thermal
cycler (Life Technologies Corporation, Carlsbad, CA). PCR products
were obtained using the following cycling conditions: 96 °C for 2 min,
followed by 35 cycles of 96 °C for 15 s, 48–56 °C for 25 s and ﬁnished
with 72 °C for 10 min. PCR efﬁciencies were assessed by standard
curve method, obtaining for all primers efﬁciencies ranging between
90 and 100%. mRNA abundance was calculated by comparative CT
(ΔΔCT) method using the formula: RQ=2−ΔΔCT [26]. The amount ofFig. 2. Ca2+ store depletion by treatment with thapsigargin modiﬁes the association of Ora
(2×109 cell/mL) were loaded with dimethyl BAPTA and then suspended in a Ca2+-free m
indicated and lysed. Whole cell lysates were immunoprecipitated (IP) with the indicated
Western blotting with speciﬁc anti-Orai2, anti-Orai1 or anti-STIM2 antibody (A) or with a
immunoprecipitation for protein loading control. The panel shows results from one experi
were determined using molecular mass markers run in the same gel. Histograms represent
at resting conditions (control) and TG-treated cells. Results are presented as percentage ofmRNA transcripts were normalized to β-actin expression and repre-
sented as (mean expression relative to Orai1±S.E.M; n=3).2.6. Cell viability
Cell viability was assessed using calcein and trypan blue. For calcein
loading, cells were incubated for 30 min with 5 μM calcein-AM at 37 °C,
centrifuged and the pellet was resuspended in fresh HBS. Fluorescence
was recorded from 2mL aliquots using a Cary Eclipse Spectrophotometer
(Varian Ltd., Madrid, Spain). Samples were excited at 494 nm and the
resulting ﬂuorescence was measured at 535 nm. The results obtained
with calcein were conﬁrmed using the trypan blue exclusion technique.i1 and Orai2 with Orai3, STIM and TRPC proteins in human platelets. Human platelets
edium (100 μM EGTA added). Cells were then stimulated for 3 min with TG (1 μM) as
antibodies and immunoprecipitates were subjected to 10% SDS-PAGE and subsequent
nti-Orai2 antibody (B and C). Membranes were reprobed with the antibody used for
ment representative of four to eleven others. Molecular masses indicated on the right
the quantiﬁcation of Orai1 (A) and Orai2 (B and C) association with the tested proteins
the respective control and expressed as mean±S.E.M. *pb0.05 versus control.
Fig. 3. Ca2+ store depletion reduces the association of Orai3 with TRPC1 and TRPC6 in
human platelets. Human platelets (2×109 cell/mL) were loaded with dimethyl BAPTA
and then suspended in a Ca2+-free medium (100 μM EGTA added). Cells were then
stimulated for 3 min with TG (1 μM) as indicated and lysed. Whole cell lysates were
immunoprecipitated (IP) with anti-TRPC1, anti-TRPC3 or anti-Orai3, as indicated.
Immunoprecipitates were subjected to 10% SDS-PAGE and subsequent Western blotting
with anti-Orai3 or anti-TRPC6 antibody. Membranes were reprobed with the antibody
used for immunoprecipitation for protein loading control. The panel shows results from
one experiment representative of four to six others. Molecular masses indicated on the
right were determined using molecular mass markers run in the same gel. Histograms
represent the quantiﬁcation of Orai3 association with the mentioned proteins at rest
(control) and TG-treated cells. Results are presented as percentage of the respective
control and expressed as mean±S.E.M. *pb0.05 versus control.
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The immunoprecipitation and Western blotting were performed
as described previously [11,27]. Brieﬂy, 500 μL aliquots of platelet
suspension (2×109 cell/mL) were lysed with an equal volume of
RIPA buffer, pH 7.2, containing 316 mM NaCl, 20 mM Tris, 2 mM
EGTA, 0.2% SDS, 2% sodium deoxycholate, 2% triton X-100, 2 mM
Na3VO4, 2 mM PMSF, 100 μg/mL leupeptin and 10 mM benzamidine.
Aliquots of platelet lysates (1 mL) were immunoprecipitated by incu-
bation with 2 μg of either anti-Orai1 or anti-TRPC1, 1 μg of anti Orai3,
anti STIM1, anti-TRPC3 or anti-TRPC6 antibody and 25 μL of protein
A-agarose overnight at 4 °C on a rocking platform. The immunopre-
cipitates were resolved by 10% SDS-PAGE and separated proteins
were electrophoretically transferred onto nitrocellulose membranes
for subsequent probing. Blots were incubated overnight with 10%
(w/v) BSA in tris-buffered saline with 0.1% Tween 20 (TBST) to
block residual protein binding sites. Immunodetection of STIM1,
STIM2, Orai1, Orai2, Orai3, hTRPC1, hTRPC3 and hTRPC6 was achieved
using the anti-STIM1 antibody or the anti Orai1 antibody diluted
1:250 in TBST for 2 h; anti h-TRPC1 or anti-hTRPC6 diluted 1:200 or
the anti-hTRPC3 diluted 1:1000 in TBST for 2 h, respectively; or the
anti Orai2 antibody diluted 1:500, the anti Orai3 antibody diluted
1:100 or the anti-STIM2 diluted 1:400, gently shaking overnight at
4 °C. The primary antibody was removed and blots were washed six
times for 5 min each with TBST. To detect the primary antibody,
blots were incubated for 45 min with the appropriate horseradish
peroxidase-conjugated secondary antibody diluted 1:10,000 in TBST
and then exposed to enhanced chemiluminiscence reagents for
4 min. Blots were then exposed to photographic ﬁlms. The density
of bands on the ﬁlm was measured using scanning densitometry
and analyzed using ImageJ software for gel analysis from NIH. Data
were normalized to the amount of protein recovered by the antibody
used for the immunoprecipitation. Negative controls using rabbit IgG
for immunoprecipitation are shown in Supplemental Fig. 1.
For each antibody-based immunoprecipitation we performed an
antibody-free, protein A-agarose only control in order to ensure that
the proteins immunoprecipitated are not carried through by the aga-
rose alone. In addition, for each antibody used in Western blotting a
primary antibody-free control was carried out to conﬁrm that detec-
tion is speciﬁc and not due to non-speciﬁc binding by the secondary
antibody alone (data not shown).
2.8. Measurement of [Ca2+]i (cytosolic free Ca
2+ concentration)
Fluorescence was recorded from 2 mL aliquots of magnetically
stirred platelet suspension (1×108 cells/mL) at 37 °C using a ﬂuores-
cence spectrophotometer with excitation wavelengths of 340 and
380 nm and emission at 505 nm. Changes in [Ca2+]i were monitored
using the fura-2 340/380 ﬂuorescence ratio and calibrated according
to the method of Grynkiewicz et al. [28].
2.9. Statistical analysis
Analysis of statistical signiﬁcancewas performed using one-way anal-
ysis of variance. For comparison between two groups Student's t-test was
used. pb0.05 was considered to be signiﬁcant for a difference.
3. Results and discussion
The identiﬁcation of STIM1 and Orai1 as essential components of the
store-operated current ICRAC marked a milestone in the investigation of
the biophysical, biochemical and functional aspects of SOCE. Two ubiqui-
tously expressedmammalian Orai1 homologs have been described, Orai2
and Orai3, as well as one STIM1 homolog, STIM2, whose involvement in
SOCE remains unclear. To identify the expression of the different Orai
and STIM isoforms, as well as TRPC1, TRPC3 and TRPC6, we carried outRT-PCR in platelets isolated from healthy volunteers. Semi-quantitative
RT-PCR showed a single PCR band for Orai(1–3), STIM(1–2) and
TRPC(1, 3, 6) indicating signiﬁcant expression of their mRNA transcripts
in human platelets (Fig. 1A), as observed in previous studies [29–33].
Despite the high variability observed in TRPC3 and STIM1 abundance
between individuals (Fig. 1B), qRT-PCR analysis indicated a predominant
expression of Orai1 and STIM1 mRNA transcripts in human platelets as
previously observed [29,30,33], followed by TRPC6.3.1. Ca2+ store depletion induces speciﬁc association between Orais,
STIMs and TRPC proteins
As reported above using real time-PCR, we have found that human
platelets have detectable amounts of mRNA for the elementary CRAC
channel components Orai1 and STIM1, as well as Orai2, Orai3, STIM2,
and the TRPC channels TRPC1, TRPC3 and TRPC6; therefore, platelets are
an excellent model for native cells endogenously expressing STIM, Orai
and TRPC proteins in order to investigate their role in capacitative or
non-capacitative Ca2+ entry pathways. We have previously reported
functional association of Orai1with STIM1 and the TRPC subfamilymem-
bers TRPC1 and TRPC6 in humanplatelets associated to SOCE [34–37].We
therefore tested for coupling betweenOrai, STIMandTRPCproteins under
conditions that stimulated capacitative Ca2+ entry in these cells by
looking for co-immunoprecipitation fromplatelet lysates. Immunoprecip-
itation and subsequent SDS/PAGE and Western blotting were conducted
using control platelets and platelets inwhich the intracellular Ca2+ stores
Fig. 4. Treatment OAG does not signiﬁcantly modify the association of Orai1 and Orai2 with Orai3, STIM and TRPC proteins in human platelets. Human platelets (2×109 cell/mL) were
suspended in a medium containing 1 mM Ca2+ and then stimulated for 3 min with OAG (100 μM) as indicated and lysed. Whole cell lysates were immunoprecipitated (IP) with the
indicated antibodies and immunoprecipitates were subjected to 10% SDS-PAGE and subsequent Western blotting with speciﬁc anti-Orai2, anti-Orai1 or anti-STIM2 antibody (A) or
with anti-Orai2 antibody (B and C).Membraneswere reprobedwith the antibody used for immunoprecipitation for protein loading control. The panel shows results fromone experiment
representative of four to eight others.Molecularmasses indicated on the rightwere determinedusingmolecularmassmarkers run in the same gel. Histograms represent thequantiﬁcation of
Orai1 (A) and Orai2 (B and C) association with the tested proteins at resting conditions (control) and TG-treated cells. Results are presented as percentage of the respective control and
expressed as mean±S.E.M.
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absence of extracellular Ca2+ (100 μM EGTA added). Platelets heavily
loaded with the intracellular Ca2+-chelator, dimethyl-BAPTA, were used
for this study so as to eliminate Ca2+-, but not store depletion-, triggered
responses. Immunoprecipitation with the anti-Orai1 antibody followed
by Western blotting revealed the presence of Orai2 and STIM2 in resting
platelets (Fig. 2A, left and right panels), and, similarly, Orai1was detected
in samples from resting platelets immunoprecipitatedwith the anti-Orai3
antibody (Fig. 2A, middle panel), indicating association between these
proteins in resting conditions. Co-immunoprecipitation of Orai1 with
Orai2 and STIM2 was signiﬁcantly enhanced by Ca2+ store depletion,while the coupling between Orai1 and Orai3 was signiﬁcantly attenuated
by Ca2+ store discharge using TG (Fig. 2A), suggesting a facilitation of
Orai1 association with Orai2 and STIM2 in detriment of Orai3 upon
store depletion.
We have further explored the interactions of Orai2 with other pro-
teins upon depletion of the intracellular Ca2+ stores in platelets loaded
with dimethyl BAPTA. Immunoprecipitation and subsequent SDS/PAGE
and Western blotting revealed detectable association of Orai2 with
Orai3, STIM2 (Fig. 2B), TRPC1, TRPC3 and TRPC6 (Fig. 2C) in resting
platelets. As depicted in Fig. 2B (middle and right panels), immunopre-
cipitation with anti-STIM1 and anti-STIM2 antibodies and subsequent
Fig. 5. Treatment with OAG enhances the association of Orai3 with TRPC3 in human
platelets. Human platelets (2×109 cell/mL) were suspended in a medium containing
1 mM Ca2+ and then stimulated for 3 min with OAG (100 μM) as indicated and lysed.
Whole cell lysates were immunoprecipitated (IP) with anti-TRPC1, anti-TRPC3 or
anti-Orai3, as indicated. Immunoprecipitates were subjected to 10% SDS-PAGE and
subsequent Western blotting with anti-Orai3 or anti-TRPC6 antibody. Membranes
were reprobed with the antibody used for immunoprecipitation for protein loading
control. The panel shows results from one experiment representative of four to six
others. Molecular masses indicated on the right were determined using molecular
mass markers run in the same gel. Histograms represent the quantiﬁcation of Orai3
association with the mentioned proteins at rest (control) and TG-treated cells. Results
are presented as percentage of the respective control and expressed as mean±S.E.M.
*pb0.05 versus control.
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BAPTA-loaded cells, Ca2+ store depletion resulted in a signiﬁcant in-
crease in the association of Orai2 with both STIM isoforms. Similarly,
immunoprecipitation and subsequent Western blotting revealed that
the association of Orai2 with TRPC1 and TRPC6 was signiﬁcantly en-
hanced by Ca2+ store depletion (Fig. 2C, left and right panels). In con-
trast, the association of Orai2 with TRPC3 was unaffected by store
discharge (Fig. 2C, middle lane) and co-immunoprecipitation of Orai2
with Orai3 was signiﬁcantly reduced by Ca2+ store depletion (Fig. 2A,
left panel).
In human platelets, a functional involvement of both TRPC1 and
TRPC6 in capacitative Ca2+ entry has been reported [32,34,38–40];
meanwhile TRPC3 has been classically considered a non-capacitative
channel subunit [40]. In human platelets we have previously reported
the association of STIM1 with Orai1, TRPC1 and TRPC6 regulated by
the intracellular Ca2+ stores [34,35,37]. In agreement with the concept
that TRPC3 is a non-capacitative channel in human platelets, we have
now found that Ca2+ store depletion signiﬁcantly reduced the associa-
tion between both STIM1 and STIM2 with TRPC3 (Supplemental Figs. 2
and 3C), while no change in the association between STIM proteins and
TRPC3 was detected upon stimulation with OAG. We have further ex-
plored the interaction between STIM2 and STIM1, TRPC1 and TRPC6
speciﬁcally induced by Ca2+ store discharge in dimethyl BAPTA-
loaded cells. Immunoprecipitation and subsequent Western blotting
revealed that Ca2+ store depletion enhances association of STIM2
with STIM1 and TRPC1 (Supplemental Figs. 3A and B), which further
suggest the involvement of TRPC1 in the capacitative pathway. We
failed to detect co-immunoprecipitation between STIM2 and TRPC6 inhuman platelets either at resting conditions or upon stimulation with
TG (data not shown).
In summary, our results indicate that discharge of the intracellular
Ca2+ stores in platelets loaded with the intracellular chelator dimethyl
BAPTA, to prevent rises in [Ca2+]i, enhances the association of a signaling
complex involving STIM1, STIM2, Orai1, Orai2, TRPC1 and TRPC6 (see
Fig. 7). We have found that the association of Orai3 with Orai1 or Orai2
is reduced upon Ca2+ store discharge; thus suggesting that Orai3
might not be involved in the capacitative pathway. To further explore
this possibility we investigated the association of Orai3 with STIM1
and STIM2 by co-immunoprecipitation; however, we did not detect as-
sociation between Orai3 and STIM proteins either at resting conditions
or after discharge of the intracellular Ca2+ stores (data not shown). The
lack of association of Orai3 with STIM proteins upon Ca2+ store depletion
suggests that Orai3 gating is not regulated by the intracellular Ca2+ stores
in humanplatelets. To further explore the role of Orai3 in humanplatelets
we have investigated the association of Orai3with TRPC proteins in these
cells. Immunoprecipitation and subsequent Western blotting revealed
detectable association of Orai3 with TRPC1, 3 and 6 in resting platelets
(Fig. 3). Co-immunoprecipitation of Orai3with TRPC1 and TRPC6was sig-
niﬁcantly reduced by Ca2+ store depletion while the interaction of Orai3
with TRPC3was independent of the ﬁlling state of the Ca2+ stores (Fig. 3).
3.2. Formation of signaling complexes upon activation of
non-capacitative Ca2+ entry by OAG
We have further investigated the association of Orai, STIM and TRPC
proteins after stimulation of human platelets with 100 μMOAG, the di-
acylglycerol (DAG) analog, in the presence of 1 mM extracellular Ca2+,
an experimentalmaneuver that has beenwidely shown to activate non-
capacitative Ca2+ entry [41]. In human platelets, OAG is unable to
mobilize Ca2+ from internal stores but induces rapid Ca2+ entry across
plasma membrane channels [35]. In the presence of 1 mM extracellular
Ca2+, co-immunoprecipitation of Orai, STIM and TRPC proteins at rest-
ing conditions was similar to that found in dimethyl BAPTA-loaded
platelets suspended in a Ca2+-free medium (Figs. 4 and 5 vs. Figs. 2
and 3). Treatment of human platelets with OAG did not alter the co-
immunoprecipitation of Orai1 with Orai2, Orai3, and STIM2 (Fig. 4A)
or the association of Orai2 with Orai3, STIM proteins, TRPC1, TRPC3
and TRPC6 (Fig. 4B and C), indicating that non-capacitative Ca2+ entry
does not require further association between these proteins.
Interestingly, OAG signiﬁcantly enhanced the association between
Orai3 and the non-capacitative channel TRPC3, while the interaction
of Orai3 with TRPC1 or TRPC6 was unaffected by this treatment
(Fig. 5). Altogether, our observations suggest that Orai3 might func-
tion as a non-capacitative channel in human platelets. This suggestion
is based on the following ﬁndings: 1) store depletion evokes dissoci-
ation of Orai3 from Orai1, Orai2, TRPC1 and TRPC6; 2) platelet treat-
ment with the DAG analog OAG results in association of Orai3 with
the non-capacitative channel TRPC3 and 3) the lack of association of
Orai3 with STIM1 or STIM2 either in resting conditions or after stim-
ulation with TG or OAG.
We have further investigated the possible role of Orai3 in non-
capacitative Ca2+ entry in HEK-293 cells overexpressing Orai3 channels.
Our results indicate that in Orai3-expressing cell treatment with 100 μM
OAG, in the presence of 1 mM extracellular Ca2+, resulted in a signiﬁ-
cantly greater Ca2+ entry than in wild type cells (pb0.05; Fig. 6A and
B); while TG-induced Ca2+ entry was not signiﬁcantly affected by
Orai3 overexpression (data not shown).
Since Orai3 has been reported to participate in the arachidonic
acid (AA) activated ARC channels [42], and AA has been reported to
mobilize Ca2+ in human platelets [43], we explored the role of Orai3 in
AA-mediated Ca2+ inﬂux. As reported in Fig. 6C, treatment of human
platelets with 8 μM AA in a Ca2+-free medium resulted in a transient
rise in [Ca2+]i due to Ca2+ release from the intracellular stores, subse-
quent addition of Ca2+ to the extracellular medium resulted in Ca2+
Fig. 6. Orai3might be involved in arachidonic acid-mediated non-capacitative Ca2+ entry. (A)Western blottingwith anti-Orai3 antibodyof lysates fromwild typeHEK-293 cells (WT) and
HEK-293 cells overexpressing Orai3 (Orai3). (B) Fura-2-loadedwild type (WT) or Orai3-overexpressing HEK-293 cells (Orai3) were suspended in a medium containing 1 mM CaCl2 and
stimulated with 100 μM OAG. (C) Fura-2-loaded human platelets (1×108 cell/mL) were stimulated either with arachidonic acid (AA; 8 μM) in a Ca2+-free medium (100 μM EGTA was
added) followed by addition of CaCl2 (ﬁnal concentration 1 mM) two and a half minutes later to initiate Ca2+ entry. (D) Platelets were stimulated with 1 μM TG+50 nM ionomycin
in the presence of 1 mMextracellular Ca2+ and 2 min later 8 μMAAwas added to the platelet suspension. Changes in [Ca2+]i weremonitored as described inMaterial andmethods. Traces
are representative ofﬁve separate experiments. (E) Human platelets (2×109 cell/mL) were suspended in amedium containing 1 mMCa2+ and then stimulated for 3 minwith AA (8 μM)
and lysed. Whole cell lysates were immunoprecipitated (IP) with anti-Orai3 antibody, as indicated. Immunoprecipitates were subjected to 10% SDS-PAGE and subsequent Western
blotting with anti-Orai1 antibody. Membranes were reprobedwith the antibody used for immunoprecipitation for protein loading control. The panel shows results from one experiment
representative of four others. Molecular masses indicated on the right were determined using molecular mass markers run in the same gel. Histograms represent the quantiﬁcation of
Orai1–Orai3 association at rest (control) and AA-treated cells. Results are presented as percentage of the respective control and expressed as mean±S.E.M. *pb0.05 versus control.
(F) Fura-2-loaded wild type (WT) or Orai3 and Orai1-overexpressing HEK-293 cells (Orai1/3) were suspended in a Ca2+-free medium and stimulated with arachidonic acid
(AA; 8 μM) followed by addition of CaCl2 (ﬁnal concentration 1 mM) two and a half minutes later to initiate Ca2+ entry. Changes in [Ca2+]i were monitored as described in Material
and methods. Traces are representative of four separate experiments. (G) Western blotting with anti-Orai3 (top panel) or anti-Orai1 (bottom panel) antibody of lysates from wild
type HEK-293 cells (WT) and HEK-293 cells overexpressing Orai3 and Orai1 (Orai1/3).
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Fig. 7. Speculative model for the formation of Ca2+ inﬂux complexes regulated by Ca2+ store depletion or second messengers in human platelets. Left, in cells with depleted Ca2+
stores, STIM1 and STIM2 localized in the membrane of the Ca2+ stores [11,37] associate with Orai1, Orai2 and TRPC channels, including TRPC1 and TRPC6, in a Ca2+-independent
manner, on order to initiate Ca2+ entry regulated by the intracellular stores or capacitative Ca2+ inﬂux. Right, cell activation by agonists is often followed by the generation of
diacylglycerol (DAG; OAG is a DAG analog) which activates the association of Orai3 with TRPC3 independent of the ﬁlling state of the intracellular Ca2+ stores, where Orai3
might be an important element of the non-capacitative pathway for Ca2+ inﬂux in human platelets.
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cells were treated in the presence of 1 mM external Ca2+ with 1 μM TG
combined with 50 nM ionomycin, to induce extensive and permanent
depletion of the intracellular stores [44]. Once [Ca2+]i reached a plateau
addition of AA to the platelet suspension resulted in a further increase in
[Ca2+]i indicative of the activation of non-capacitative Ca2+ entry
(Fig. 6D). Since ARC channels, which consist of Orai1 and Orai3 subunits,
have been reported to conduct AA-induced Ca2+ entry in other cells [45],
we have further investigated whether AA stimulates Orai1 and Orai3 as-
sociation in humanplatelets. As shown in Fig. 6E, our results indicate that
stimulation with AA signiﬁcantly enhances association of Orai1 and
Orai3 in human platelets (pb0.05). Furthermore, we have found that
co-expression of Orai1 andOrai3 inHEK-293 cells results in enhanced ar-
achidonic acid-induced Ca2+ entry (Fig. 6F and G). Although further
electrophysiological and biophysical studies are necessary to demon-
strate the presence of ARC channels in human platelets, our ﬁndings sug-
gest that, in agreement with previous studies [45,46], there is an
interplay between Orai3 subunits and AA in these cells.
The contribution of Orai3, as well as that of STIM2 and Orai2, to
capacitative or non-capacitative Ca2+ entry in native cells remains
unclear. In cultured myoblasts derived from human muscle biopsies
silencing of STIM1, Orai1 and Orai3 has been reported to attenuate
capacitative Ca2+ inﬂux, while Orai2 knockdown was without effect
[20]. By contrast, in vascular smooth muscle cells from rat aorta si-
lencing of STIM1 and Orai1, but not that of Orai2 and Orai3, markedly
reduced capacitative Ca2+ entry [19], and similar observations have
been reported in primary cultured proliferating human aortic smooth
muscle cells [47]. In addition, co-expression of Orai1 and Orai2 with
STIM1 signiﬁcantly enhanced ICRAC, while Orai3 failed to reproduce
this current [7,48]. Furthermore, co-expression of STIM1 with the
murine orthologs of Orai2 had a minor effect on capacitative Ca2+entry, and similar results were observed with Orai3, while co-
expression with the murine ortholog of Orai1 markedly increased
capacitative Ca2+ inﬂux [23]. Co-expression of Orai2 with STIM1 has
been reported to amplify ICRAC in HEK293 but not in RBL 2H3 cells,
while Orai1 has been found to enhance ICRAC in both cell lines under
the same experimental maneuver [49]. A role for Orai3 in ICRAC has
been reported in estrogen receptor-positive breast cancer cell lines
mediated by STIM1 and STIM2 [50]. Altogether these ﬁndings suggest
that, while in exogenous expression systems Orai2 plays a role in
capacitative Ca2+ inﬂux and Orai3 fails to reproduce this current,
the ability of Orai2 and Orai3 to form capacitative channels in native
cells strongly depends on the cell background.
In human platelets, our results indicate that Ca2+ store depletion
results in the formation of a macromolecular complex possibly regu-
lated by STIM1 and STIM2 proteins. The present and previous obser-
vations reported by us under the same conditions [34] indicate that
STIM1, but not STIM2, associates with TRPC6 upon store depletion,
thus suggesting that both STIM isoforms might ﬁnely regulate speciﬁc
signals activated by depletion of discrete intracellular Ca2+ compart-
ments and where the participation of different Ca2+-permeable chan-
nel subunits, including Orai and TRPC isoforms, for the conduction of
SOCE might provide the cell with a battery of possibilities for a range
of Ca2+ signals, from Ca2+ selective to non-selective cationic cur-
rents. In summary, our results provide the ﬁrst evidence for the par-
ticipation of Orai2 and STIM2 in the store-operated macromolecular
complex that mediates SOCE in human platelets, as well as suggest
a non-capacitative role for Orai3 in these cells probably participating
in a DAG-regulated channel involving TRPC3 (Fig. 7). The rationale of
the presence of different channels to conduct Ca2+ entry, probably
associated or independent on lipid rafts as previously reported [1,2],
might be explained by the variety of Ca2+ signals generated by
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mention that human platelets contain two distinct intracellular Ca2+
stores, expressing STIM1 and STIM2 [3], that activate store-operated
Ca2+ entry by different mechanisms [4]. Platelet agonists have been
shown to induce Ca2+ release exclusively from the dense tubular sys-
tem, such as ADP or AVP, or from the dense tubular system and the
acidic stores, in the case of thrombin and depending on the agonist
concentration [5].Acknowledgements
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